...said the U.K. Supreme Court granted it permission to intervene in the court's review of Warner-Lambert...
...case involves a patent for the use of Lyrica pregabalin from Pfizer Inc. (NYSE:PFE), which Warner-Lambert...
...disorder and epilepsy. After Generics Ltd. and Actavis commenced claims to revoke Warner-Lambert's patent and Warner-Lambert...

...an aggregator, acquiring large companies and integrating them into its portfolio. In 2000, it acquired Warner-Lambert...

...Bayer AG , Bristol-Myers Squibb Co. , British Biotech plc (now Vernalis plc ) and Warner-Lambert...

...the company acquired hairy cell leukemia drug Nipent pentostatin for undisclosed cash and equity from Warner-Lambert...

...markets moxifloxacin, a fluoroquinolone antibiotic, under multiple brand names. Clinafloxacin was originally being developed by Warner-Lambert...

...Pfizer Inc. (NYSE:PFE), which enabled the pharma to satisfy FTC requirements for its merger with Warner-Lambert...

...but they were generally unsuccessful in getting compliance to test for liver function," he said. Warner-Lambert...

...'new information' up in the Vermont courts," Bradshaw said. He added that in another case, Warner-Lambert...